Veytics Intelligence
2026-10-10 · NASDAQ

Alnylam vs. Ionis: Here's the Better Bad-News Buy

Key PointsAlnylam cut its full-year revenue guidance due to slower-than-expected sales for Amvuttra.

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。